Identification, monitoring and treatment of disease and...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C702S019000, C702S020000

Reexamination Certificate

active

06964850

ABSTRACT:
Gene expression data, in particular gene expression profiles, are created and used in the identification, monitoring and treatment of disease and characterization of biological conditions. Profile data sets are derived from subject samples and include quantitative substantially repeatable measures of a distinct amount of RNA or protein constituent in a panel selected to enable evaluation of a biological condition. Such profile data sets may be used to provide an index indicative of the biological state of a subject, which may be compared to a normative value of the index determined with respect to a relevant population of subjects.

REFERENCES:
patent: 5643765 (1997-07-01), Willey
patent: 5696130 (1997-12-01), Jones et al.
patent: 5811231 (1998-09-01), Farr et al.
patent: 5846720 (1998-12-01), Foulkes et al.
patent: 5866330 (1999-02-01), Kinzier et al.
patent: 5955269 (1999-09-01), Ghai et al.
patent: 5968784 (1999-10-01), Spinella et al.
patent: 5994076 (1999-11-01), Chenchik et al.
patent: 6132969 (2000-10-01), Stoughton et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6150169 (2000-11-01), Smith et al.
patent: 6165709 (2000-12-01), Friend et al.
patent: 6185561 (2001-02-01), Balaban et al.
patent: 6203987 (2001-03-01), Friend et al.
patent: 6203988 (2001-03-01), Kambara et al.
patent: 6218122 (2001-04-01), Friend et al.
patent: 6222093 (2001-04-01), Marton et al.
patent: 6232065 (2001-05-01), Robinson et al.
patent: 6245517 (2001-06-01), Chen et al.
patent: 2001/0018182 (2001-08-01), Friend et al.
patent: 2001/0029028 (2001-10-01), Foote
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2002/0012932 (2002-01-01), Wang
patent: 2002/0045197 (2002-04-01), Friend et al.
patent: 10-261029 (1998-09-01), None
patent: WO 94/23023 (1994-10-01), None
patent: WO 97/41261 (1997-06-01), None
patent: WO 98/24935 (1998-06-01), None
patent: WO 98/24935 (1998-11-01), None
patent: WO 99/04251 (1999-01-01), None
patent: WO 99/44063 (1999-02-01), None
patent: WO 99/46403 (1999-09-01), None
patent: WO 99/54510 (1999-10-01), None
patent: WO 99/54510 (1999-10-01), None
patent: WO 99/11822 (1999-11-01), None
patent: WO 99/57130 (1999-11-01), None
patent: WO 99/58720 (1999-11-01), None
patent: WO 00/11208 (2000-02-01), None
patent: WO 00/22172 (2000-04-01), None
patent: WO 00/28092 (2000-05-01), None
patent: WO 00/71756 (2000-11-01), None
patent: WO 01/11082 (2001-02-01), None
patent: WO 01/12851 (2001-02-01), None
patent: WO 01/20998 (2001-03-01), None
patent: WO 01/23614 (2001-04-01), None
patent: WO 01/25473 (2001-04-01), None
patent: WO 01/27321 (2001-04-01), None
patent: WO 01/29261 (2001-04-01), None
patent: WO 01/29269 (2001-04-01), None
patent: WO 01/30972 (2001-05-01), None
patent: WO 01/32928 (2001-05-01), None
patent: WO 03/040404 (2003-05-01), None
Asthana, D., et al., Differential Effects of IFN-γ on Kidney Cell Expression of MHC Class II Molecules, Kidney Cell Associated Molecules and Their Stimulatory Capacity in Mixed Lymphocyte Kidney Cell Culture;Transpl Immunol, vol. 1, pp. 282-293; 1993.
Beer, David G., et al., “Gene-Expression Profiles Predict Survival of Patients With Lung Adenocarcinoma,”Nature Medicine, Aug. 2002, vol. 8, No. 8, pp. 816-824.
Buchwald, D., et al., Markers of Inflammation and Immune Activation in Chronic Fatigue and Chronic Fatigue Syndrome;J Rheumatol, vol. 24, pp. 372-376; 1997.
Coenen, et al, “A quantitative PCR measurement of messenger RNA expression of IGF-I, IFG-II and IGFBP-5 in human skeletal muscle”,Growth Hormone&IGF Research1999,9,179-186 Article No.ghir.1999.0104.
Eisenberg, et al., “Protein Function in the Post-Genomic Era,”Nature, vol. 405:823-826, Jun. 15, 2000.
Guan-Chiun Lee, et al, Analysis of the Gene Family Encoding Lipases incandid rugosaby Competitive Reverse Tanscription-PCR,Applied and Environmental Microbiology, Sep. 1999, pp. 3888-3895.
Humbert, M., et al., Relationship Between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma;Am J Respir Crit Care Med, vol. 156, pp. 704-708, 1997.
Imai, S., et al., High Levels of Expression of Collagenase-3 (MMP-13) in Pathological Conditions Associated with a Foreign-Body Reaction;J Bone Joint Surg, vol. 80-B, pp. 701-710, Jul. 1998.
Jensen, et al, “Competitive reverse transcription polymerase chain reaction for quantifying pre-MRNA and mRNA of major acute phase proteins”,Journal of Immunological Methods, 215 (1998), pp. 45-58.
Kim, et al., “Strong Feature Sets from Small Samples”, Journal of Computational Biology, vol. 9, No. 1, 2002, Mary Ann Liebert, Inc. pp. 1127-1146.
Korenberg, “Prediction of Treatment Response Using Gene Expression Profiles”,Journal of Proteome Research 2002, 1, 55-61.
Lockhart, et al., “Genomics, Gene expression and DNA Arrays,”Nature, vol. 405:827-836, Jun. 15, 2000.
Loitsch, et al, “Reverse Transcription-Competitive Multiplex PCR Improves Quantification and mRNA in Clinical Samples-Application to the Low Abundance CFTR mRNA”,Clinical Chemistry45:5, (1999), pp. 619-624.
Mangalam, et al., “Gene X: An open source gene expression database and integrated tool set”, IBM Systems Journal,(2001), 40 (2), 552-569, 79 refs. ISSN: 0018-8670.
Meijers-Heijboer, M.D., et al., “Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation”, The New England Journal of Medicine, vol. 345:159-164, Jul. 19, 2001, No. 3.
Ono, K., et al., Cytokine Gene Expression After Myocardial Infarction in Rat Hearts (Possible Implication in Left Ventricular Remodeling);Circulationvol. 98, pp. 149-156, Jul. 14, 1998.
Pandey, et al., “Proteomics to Study Genes and Genomes,”Nature, vol. 405:837-846, Jun. 15, 2000.
Rafalski, et al., “New experimental and computational approaches to the analysis of gene expression”, Acta Biochimica Polonica, vol. 45, No. 4/1998, 929-934.
Reinke, P., et al., “Immune Monitoring of Glucocorticoid Therapy,”Ernst Schering Research Foundation Workshop. Germany 2002, No. 40, pp. 25-37.
Risch, “Searching for Genetic Determinants in the New Millennium,”Nature, vol. 405:847-856, Jun. 15, 2000.
Rosenwald, M.D., et al, “The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma”, The New England Journal of Medicine, vol. 346:1937-1947, Jun. 20, 2002, No. 25.
Roses, “Pharmacogenetics and the Practice of Medicine,”Nature, vol. 405:857-865, Jun. 15, 2000.
Skedinger, M., et al., Eosinophil Activity Reflects Clinical Status in Patients with Asthma Before and During a Prednisolone Course;Ann Allergy Asthma Immunol, vol. 75, pp. 250-255, Sep. 1995.
Staunton, et al., “Chemosensitivity predication by transcriptional profiling”, Proc. Natl. Acad. Sci. USA, vol. 98, Issue 19, 10787-10792, Sep. 11, 2001.
Teague, et al, “Activation changes the spectrum but not the diveristy of genes expressed by T cells”, Proc. Natl. Acad. Sci. USA, vol. 96, Issue 22, 12691-12696, Oct. 26, 1999.
Van 't Veer, et al., “Gene expression profiling predicts clinical outcome of breast cancer”, Nature, vol. 415, Jan. 31, 2002.
Vukmirovic, et al., “Exploring Genome Space,”Nature, vol. 405:820-822, Jun. 15, 2000.
Zajchowski, et al., “Identification of Gene Expression Profiles That Predict the Aggressive Behavior of Breast Cancer Cells”, Cancer Research 6, 5168-5178, Jul. 1, 2001.
Zhan, et al., “Gloral Gene Expression Profiles Can be Used to Accurately Predict Chromosome 13 Deletion in Multiple Myeloma”, Abstract #1553, Poster Board #-Session: 658-II.
Zhang, et al, “A Novel Highly Reproducible Quantitative Competitive RT PCR System”,J. Mol. Biol(1997) 274, pp. 338-352.
Zhang, et al., “Recursive partitioning for tumor classification with gene expression microarray data”, Proc. Natl. Acad. Sci, USA, vol. 98, Issue 12, 6730-6735, Jun. 5, 2001.
PE Applied Biosystems Manual, “

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Identification, monitoring and treatment of disease and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identification, monitoring and treatment of disease and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification, monitoring and treatment of disease and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3457170

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.